Healthcare
Why Is This Medical Company Soaring On ASX - Reva Medical?
November 06, 2018 07:30 AM AEDT| By Team Kalkine MediaREVA Medical, Inc. (ASX: RVA) is a leader in bioresorbable polymer technologies for vascular medical applications; and despite the increasing challenges in the European BS market, substantial growth in the product shipments and new customers acquisit...
Cellmid - Anti-Baldness Company – Disappointed With Outcome As It Loses Court Case
November 06, 2018 03:56 AM AEDT| By Team Kalkine MediaCellmid, the anti-baldness company loses court case against its former marketing agency which has forced the company to spend nearly $1 million. Cellmid (ASX: CDY) is developing cancer and heart disease treatments and makes hair growth tonics. Its ha...
Clinuvel Pharmaceuticals Shares Uplifted By 8.6 Percent After The Release Of Company’s Newsletter
November 05, 2018 01:10 PM AEDT| By Team Kalkine MediaIn the recently released quarterly results, Clinuvel Pharmaceuticals Limited (ASX: CUV) confirmed the steady growth in clinical demand for SCENESSE? in erythropoietic protoporphyria (EPP) which is a rare genetic metabolic disorder. The Cash receipts...
Clover Makes Investment In Melody Dairies: What Investors Need To Know
November 05, 2018 05:59 AM AEDT| By Team Kalkine MediaOn November 5, 2018, Clover Corporation Limited (ASX: CLV) came forward and made an announcement that it has made an acquisition of 35% stake in Melody Dairies which is situated in Waikato Innovation Park in Hamilton, New Zealand. This marks the comp...
Cann Group Limited Betting On The Development Of First Big Glass Roof Factory
November 05, 2018 05:46 AM AEDT| By Team Kalkine MediaCann Group Limited (ASX: CAN) with its strong long term objective to be the Australian industry leader and? to develop sufficient capacity to serve expanding export markets and with its ?continuous focus on the development of the medicinal cannabis a...
Cochlear Limited’s Shares Plunged On Unfavorable Outcome Of Ruling In USA Patent Infringement Case
November 05, 2018 02:28 AM AEDT| By Team Kalkine MediaOn 5 November 2018, Cochlear Limited (ASX: COH) announced that the United States District Court in Los Angeles has ruled against the company in the patent infringement lawsuit by the Alfred E. Mann Foundation for Scientific Research (AMF) and Advance...
Healthscope Trading At Low Levels With Growing Investor-Driven Pressure
November 02, 2018 07:08 AM AEDT| By Team Kalkine MediaHealthscope Limited (ASX:HSO) is facing tough pressure from its investors. Joining the list of Healthscope shareholders, DNR capital has also raised questions to the chairman Paula Dwyer, regarding the disclosure of the company's books to a private e...
Living Cell Technologies’ Shares Trading In Green Zone After The Release Of Trial Results From Phase IIb Study Of NTCELL
November 02, 2018 05:21 AM AEDT| By Team Kalkine MediaLiving Cell Technologies Limited (ASX: LCT) has presented the trial results from the Phase IIb study of NTCELL for Parkinson's disease. The trial commenced in March month of year 2016. The lead product of LCT, which is NTCELL is a capsule coated with...
One Pot Stock That Soared Up After Securing Potential Manufacture Licence – Althea!
November 02, 2018 02:37 AM AEDT| By Team Kalkine MediaAlthea Group Holdings Limited?s (ASX:AGH) wholly owned subsidiary Althea Company Pty Ltd has secured the manufacture licence from the Australian Government?s Office of Drug Control on November 02, i.e., today. Including this licence, Althea now holds...
RACE Oncology Limited Is On Upswing After The Appointment Of Biosynergy
November 01, 2018 07:36 AM AEDT| By Team Kalkine MediaRACE Oncology Limited (ASX:RAC) has executed the service agreement with New York based Biosynergy partners LLC, in order to pursue licensing of Bisantrene and other deals for the agreement. The Biosynergy partners is owned by one of the previous dire...
Why Is Japara Healthcare Edging Up On ASX?
November 01, 2018 04:03 AM AEDT| By Team Kalkine MediaUp 1.78% on November 01, 2018 (1:50 PM AEST), Japara HealthCare Limited (ASX:JHC) had its annual general meeting organized as on October 31, 2018, addressing all its shareholders. Management provided a brief review on FY18 operations and management?s...
Nib Soars As Management Uplifted FY19 Earning Guidance
October 31, 2018 08:49 AM AEDT| By Team Kalkine MediaHealth insurer Nib Holdings surged up 6.334% on uplifted earnings guidance for Fiscal 2019. After going up by $0.330, nib?s stock price closed at $5.540 on the day of its Annual General Meeting, 31 October 2018. Early this morning nib unveiled its u...
Biotron Slips After Its Reply To ASX
October 31, 2018 08:31 AM AEDT| By Team Kalkine MediaBiotron Limited (ASX:BIT) has shown a huge growth potential this year. Current market capitalization of Biotron stands at $90.32 mn as on October 31, 2018 i.e., today. Grown from a market cap of $10 mn to the current market cap of $90.32 mn shows the...
Healthscope Edges Up On AGM Address
October 31, 2018 07:07 AM AEDT| By Team Kalkine MediaHealthscope Ltd (ASX:HSO) had its annual general meeting organized as on October 31, 2018. Financial health check-up along with FY19 guidance were presented in this AGM. 3.7% rise in the group revenue up to $ 2.3 billion was posted in FY18 as compar...
G Medical Innovations’ CEO Yacov Geva Pumps In More Cash To Fund Company’s Growth
October 31, 2018 06:46 AM AEDT| By Team Kalkine MediaThe chief executive officer and president of G Medical Innovations? (ASX: GMV) Yacov Geva has pumped in his personal cash into the company worth US$10 million in the form of loan this time. Earlier also he had provided an amount of US$3 million to su...
3 Stocks In Healthcare Space - GMV, BD1, and SUD
October 30, 2018 04:54 AM AEDT| By Team Kalkine MediaG Medical Innovations Holdings Ltd. (ASX: GMV) G Medical Innovations Holdings Ltd. (ASX: GMV) is a leading health care company is Australia. ?In the first half of FY 2018, the company reported a net loss of US$8.509 million against a loss of US$21.74...
Stage 1 Trial Of NANABIS Is A Success. DSMB Showed A Green Flag To Proceed Towards Stage 2
October 30, 2018 04:10 AM AEDT| By Team Kalkine MediaTrial Background Information: The RNS trial was performed under 2 distinct stages. In stage 1 of the trial which is the safety and tolerable phase where patients get admitted into the hospital for 48 hours. Patients are prescribed a NanaBis starting...
Capio Shareholders Have Given A Green Card To $1.3 Billion Acquisition Bid From Ramsay
October 29, 2018 01:07 PM AEDT| By Team Kalkine MediaDespite struggling through the weaker financial performance Ramsay Health Care Limited ?(ASX: RHC) got a heads up to the acquisition of Sweden based healthcare group Capio AB. In today?s announcement to Australian Securities Exchange, Ramsay Health...
PharmAust To Increase Production of Monepantel: What You Should Know
October 29, 2018 06:39 AM AEDT| By Team Kalkine MediaPharmAust Limited (ASX: PAA) is all set to increase the development of the drug candidate named ?Monepantel? which is applicable to the pets and humans. In the present scenario, Monepantel is being marketed as well as registered as a drug which could...
Q2FY2019 Will Not Suffer The Hindrances Of Q1FY2019- Says Myles Anceschi
October 29, 2018 04:03 AM AEDT| By Team Kalkine MediaBefore the commencement of the AGM on Wednesday 31 October 2018, BWX Limited (ASX: BWX) made an announcement that for the 2019 financial year (FY19) the company expects that earnings before interest and tax (EBITDA) similar to the FY18 EBITDA of A$40...
Advertise your brand on Kalkine Media